Byotrol – full-year results, it right to have had concerns about the overall performance?
Previously writing on antimicrobial company Byotrol (BYOT), in March with the shares up to 3.15p I questioned the overall performance despite it arguing a significant improvement in product sales. So what of now-announced results for its year ended 31st March 2022?
- By Steve Moore
- 2022-08-30 11:58:41